The Global Single-Use Bioprocessing Market is valued at approximately USD 29.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.1% over the forecast period 2024-2032. Single-use bioprocessing has revolutionized the biopharmaceutical industry by offering flexible, cost-effective, and efficient solutions for bioproduction. These systems, which primarily include disposable bioreactors, filtration assemblies, and media bags, are pivotal in reducing cross-contamination risks, lowering operational costs, and accelerating the time-to-market for biopharmaceutical products. The rising demand for biopharmaceuticals, driven by advancements in biologics and personalized medicine, has significantly propelled the adoption of single-use technologies. Furthermore, the growing prevalence of chronic diseases and an aging population underscore the importance of efficient biomanufacturing processes, thereby bolstering the market's growth trajectory.
The Global Single-Use Bioprocessing Market is witnessing robust expansion, attributed to several various applications such as storage, filtration, and mixing is a major growth driver. Single-use systems are particularly favored for their ability to enhance process efficiency and reduce costs associated with the sterilization and maintenance of traditional stainless-steel bioreactors. Additionally, the extensive utilization of single-use systems in producing cell therapies, vaccines, and cancer treatments is contributing to the market's growth. However, challenges such as the high initial investment costs and the complexity of scaling up processes may temper the market's expansion over the forecast period.
The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The market for single-use bioprocessing is experiencing notable regional variations, with North America leading the global market. The region's dominance is driven by its well-established biopharmaceutical industry, significant investment in research and development, and a robust regulatory framework. The U.S. has seen substantial government support for biopharmaceutical innovation, including considerable funding for COVID-19 vaccine development. Meanwhile, the Asia Pacific region is poised for fastest growth, spurred by the increasing adoption of single-use technologies in emerging economies such as China and India. The region's growth is further accelerated by investments from biotechnology and pharmaceutical companies, aiming to capitalize on the expanding healthcare markets in these countries.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Sartorius AG
Merck KGaA
Pall Corporation
Corning Incorporated
Eppendorf AG
General Electric Company (GE Healthcare)
Lonza
Rentschler Biopharma SE
JM BioConnect
Meissner Filtration Products, Inc.
Infors AG
Boehringer Ingelheim GmbH
Entegris, Inc.
PBS Biotech, Inc.
The detailed segments and sub-segment of the market are explained below:
By Product:
Filtration Assemblies
Disposable Bioreactors
Disposable Mixers
Media Bags & Containers
Others
By Application:
Filtration
Purification
Cell Culture
Others
By End User:
Biopharmaceutical Manufacturers
Clinical & Academic Research Institutes
Others
By Workflow:
Upstream
Fermentation
Downstream
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
The Global Single-Use Bioprocessing Market is valued at approximately USD...
The Global Single-Use Bioprocessing Market is valued at approximately USD 29.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 16.1% over the forecast period 2024-2032. Single-use bioprocessing has revolutionized the biopharmaceutical industry by offering flexible, cost-effective, and efficient solutions for bioproduction. These systems, which primarily include disposable bioreactors, filtration assemblies, and media bags, are pivotal in reducing cross-contamination risks, lowering operational costs, and accelerating the time-to-market for biopharmaceutical products. The rising demand for biopharmaceuticals, driven by advancements in biologics and personalized medicine, has significantly propelled the adoption of single-use technologies. Furthermore, the growing prevalence of chronic diseases and an aging population underscore the importance of efficient biomanufacturing processes, thereby bolstering the market's growth trajectory.
The Global Single-Use Bioprocessing Market is witnessing robust expansion, attributed to several various applications such as storage, filtration, and mixing is a major growth driver. Single-use systems are particularly favored for their ability to enhance process efficiency and reduce costs associated with the sterilization and maintenance of traditional stainless-steel bioreactors. Additionally, the extensive utilization of single-use systems in producing cell therapies, vaccines, and cancer treatments is contributing to the market's growth. However, challenges such as the high initial investment costs and the complexity of scaling up processes may temper the market's expansion over the forecast period.
The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The market for single-use bioprocessing is experiencing notable regional variations, with North America leading the global market. The region's dominance is driven by its well-established biopharmaceutical industry, significant investment in research and development, and a robust regulatory framework. The U.S. has seen substantial government support for biopharmaceutical innovation, including considerable funding for COVID-19 vaccine development. Meanwhile, the Asia Pacific region is poised for fastest growth, spurred by the increasing adoption of single-use technologies in emerging economies such as China and India. The region's growth is further accelerated by investments from biotechnology and pharmaceutical companies, aiming to capitalize on the expanding healthcare markets in these countries.
Major market players included in this report are:
Thermo Fisher Scientific, Inc.
Sartorius AG
Merck KGaA
Pall Corporation
Corning Incorporated
Eppendorf AG
General Electric Company (GE Healthcare)
Lonza
Rentschler Biopharma SE
JM BioConnect
Meissner Filtration Products, Inc.
Infors AG
Boehringer Ingelheim GmbH
Entegris, Inc.
PBS Biotech, Inc.
The detailed segments and sub-segment of the market are explained below:
By Product:
Filtration Assemblies
Disposable Bioreactors
Disposable Mixers
Media Bags & Containers
Others
By Application:
Filtration
Purification
Cell Culture
Others
By End User:
Biopharmaceutical Manufacturers
Clinical & Academic Research Institutes
Others
By Workflow:
Upstream
Fermentation
Downstream
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.
All Fields are mandatory *
Corporate Email ID Only
(Avoid Using Generic mail ID such as Gmail, Yahoo, Hotmail)
OUR CLIENTS
SIGN UP FOR NEWSLETTER
500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES